Core snRNP proteins bind snRNA through the conserved Sm site, PuA(U) n≥3 GPu. While yeast U1 snRNA has three matches to the Sm consensus, the U1 3′-terminal Sm site was found to be both necessary and sufficient for U1 function. Mutation of this site inhibited pre-mRNA splicing, blocked cell division and resulted in the accumulation of two 3′-extended forms of the U1 snRNA. Cells which harbor the Sm site mutation lack mature U1 RNA (U1α) but have a minor polyadenylated species, U1γ, and a prominent, non-polyadenylated species, U1β. Metabolic depletion of the essential Sm core protein, Smd1p, also resulted in the increased accumulation of U1β and U1γ. In vitro, synthetic U1 precursors were cleaved by Rnt1p (RNase III) very near the U1β 3′-end observed in vivo. We propose that U1β is an Rnt1p-cleaved intermediate and that U1 maturation to the U1α form occurs through an Sm-sensitive step. Interestingly, both U1α and a second, much longer RNA, U1ε, were produced in an rnt1 mutant strain. These results suggest that yeast U1 snRNA processing may progress through Rnt1p-dependent and Rnt1p-independent pathways, both of which require a functional Sm site for final snRNA maturation.
INTRODUCTION
Soon after synthesis, the spliceosomal snRNAs are exported to the cytoplasm where they bind the phylogenetically conserved set of common snRNP proteins: B, B′, D1, D2, D3, E, F and G (1, 2) . The common snRNP proteins are bound through an RNA element, the Sm site, which contains the sequence PuA(U) n≥3 GPu (3, 4) . The Sm site-common protein interaction stabilizes the snRNA (5) (6) (7) (8) and is required for, or assists in, cap hypermethylation (9) and subsequent nuclear import through the β-importin/RAN GTPase-dependent pathway (10) (11) (12) (13) . The role of common snRNP proteins in splicing is unknown although there is experimental evidence suggesting that the common proteins help recruit the snRNP-specific proteins required for splicing (14, 15) .
ATP-independent interactions between the U1 snRNP particle and the pre-mRNA 5′ splice site and branch point regions nucleate the assembly of the spliceosome (reviewed in 16). In metazoa, the U1 snRNP consists of the common snRNP proteins and a set of three snRNP-specific proteins, U1-A, U1-C and U1-70K (reviewed in 17, 18) . The highly unusual Saccharomyces cerevisiae U1 snRNP possesses equivalents of each of the metazoan common and snRNP-specific proteins (19 and references cited therein) and five proteins not observed in vertebrates, Prp39p (20) , Prp40p (21), Prp42p (22) , Snu56p/Mud10p and Snu71p, as well as a possible sixth protein, Npl3p (19) . Some of these additional proteins likely interact with the yeast-specific snRNA core, an insertion which expands yeast U1 snRNA to 3.5 times the length of its vertebrate counterparts (23, 24) . All of the known yeast-specific proteins (except Np13p) are essential and likely contribute directly to U1 snRNP assembly or function.
Embedded within the extraordinarily large yeast U1 snRNA are three matches to the Sm consensus element (23, 24) . In the present investigation we used a mutagenesis approach to learn whether any or all of these putative Sm sites support biological function. Our results show that a single 3′-terminal Sm site is both necessary and sufficient for U1 snRNP function in splicing. In addition, this study reveals that U1 snRNA 3′-end formation is strictly Sm site-dependent. Perturbation of the Sm RNP structure by Sm site mutation or the removal of a core protein causes increased intracellular accumulation of 3′-extended U1 snRNA forms. Two RNase III cleavage sites were identified directly 3′ of the U1 snRNA gene body. Curiously, unlike what has been observed for U2 (25) and U5L (26) , mutation of the yeast RNase III gene, RNT1, does not reduce the level of mature U1 snRNA but, rather, causes the accumulation of a third form of lengthened U1 snRNA. This study supports a model in which yeast U1 snRNA is processed along two parallel or convergent pathways, both of which pass through an Sm-dependent step.
MATERIALS AND METHODS

Oligonucleotides
U1-2, 5′-CCC GAA TTC ATA CTT ACC TTA AGA TAT CA-3′; U1-3, 5′-GGG AAG CTT AAA ATA AAT CAA AAA TTA TAA G-3′; U1-6, 5′-ATC AGT AGG ACT TCT TGA TC-3′; U1-9, 5′-CGT ATG TGT GTG TGA CCA AG-3′; U1-10, 5′-AAC AAG GGA ATG GAA ACG TC-3′; U1-16, 5′-GAT CAG TAG GAC TTC TTG ATC-3′; U1-22, 5′-GGG TGG ATC TTA TAA TTC ACA CTT TAT TTT CAG AAA TAA ATG G-3′; U1-23, 5′-CCA TTT ATT TCT GAA AAT AAA GTG TGA ATT ATA  AGA TCC ACC C-3′; U1-24, 5′-GGG CAA GAA GCT TGA  TAT ACA ACA C-3′; U1-25, 5′-GGA ACA TTT TTC TAT TTA  TTT C-3′; pTZ-80, 5′-ACG CCA GCT GGC GAA AGG  GGG-3′; SPP381-8, 5′-ATG AGT TTT AGA CAT TTC AAG  AGG- (29) .
Plasmid construction and analysis
The full-length SNR19 (U1) gene was subcloned as a 2.3 kb AccI-HindIII fragment (23) into the TRP1-marked Escherichia coli/yeast shuttle vector YEplac112 (US Biochemical; 30). Construction of the U1∆192-507 functional deletion mutant was previously described (31) . To be compatible with the yeast strains used, U1∆192-507 was transferred as a 900 bp HindIII fragment from pSE358 (31) into vector YEplac112. Sm site mutations were introduced into SNR19 (U1) and U1∆192-507 by site-specific mutagenesis (32, 33) with oligonucleotides U1-3 and U1-24. The resulting mutant alleles, U1Sm and U1∆192-507Sm, were confirmed by DNA sequence analysis prior to yeast transformation. Yeast strains XLT10-pXL46 (27) and BZYO-14 were used as hosts for the plasmid-expressed U1 genes. The GAL::SMD1HA-containing strain, BZY1-16d, has been described elsewhere (5) . To place GAL::SMD1HA and U1∆192-507 in the same genetic background, strain BZY1-16d was crossed with PSU1∆192-507 and the diploid progeny selected on galactose-containing medium that lacked uracil and tryptophan. The diploid strain was sporulated and Trp-positive, galactose-dependent haploid progeny identified. Northern analysis with a U1-specific probe was then used to identify yeast that expressed U1∆192-507 as the sole source of U1 snRNA.
RNA analysis
Total cellular RNA was extracted from logarithmically growing cultures by glass bead disruption followed by phenol extraction and ethanol precipitation (34) . To metabolically deplete U1 snRNA or Smd1HAp, the appropriate yeast strain (XLT10-pXL46, RSY1, RSY2, BZY0-14, RSY3 or BZY2-51a) was initially cultured in 1% yeast extract, 2% Bactopeptone, 2% galactose broth (YPgal) (35) to mid-log phase at 30_C. The cells were then collected by centrifugation at 7000 g and resuspended in the same medium with 2% glucose substituted as the sugar (YPglu). All cultures were incubated with periodic dilution to maintain cell densities below 1 × 10 7 cells/ml. RNA samples isolated from these cultures were fractionated on denaturing 1% agarose-0.22 M formaldehyde gels or on 7 M urea-5% polyacrylamide gels (29) . Northern transfers were hybridized with random prime-labeled PCR fragments corresponding to RP51A intron plus exon sequences (29) , mature U1 snRNA (primers U1-2 and U1-3) and U1 downstream sequences (primers U1-25 and pTZ-80). RNA from yeast that express GAL::U1, U1∆192-507 (strain PAY4∆192-507), GAL::U1, U1∆192-507Sm (strain RSY1), U1∆192-507 (strain PSU1∆192-507), GAL::U1 (strain XLT10-pXL46), GAL::U1, U1Sm (strain RSY2), GAL::SMD1HA, U1∆192-507 (strain BZY2-51a), rnt1::HIS3 (strain MA52) and RNT1 (strain MA6) were analyzed by this method.
Oligonucleotide-directed RNase H cleavage was done essentially as described (36) . Ten micrograms of RNA was denatured at 70_C for 10 min in 19 µl of 1 mM EDTA, pH 7.4. Next, 1 µg of oligonucleotide U1-10, SPP381-8 or oligo(dT) 20 was added and the hybridization mixture incubated at 26_C for 15 min. One microliter of 4 M KCl was added and the incubation continued for 15 min at 26_C. To effect cleavage, 20 µl of TM buffer (40 mM Tris-HCl, pH 7.6, 60 mM MgCl 2 ) and 1 U of E.coli RNase H (Gibco BRL) were added for 30 min at 37_C. The RNAs were then phenol extracted, concentrated by ethanol precipitation and used for northern analysis. RNA from yeast that express GAL::SMD1HA, U1∆192-507 (strain BZY2-51a) and GAL::U1, U1∆192-507Sm (strain RSY1) were analyzed by this method.
For the RNase protection assays (36) , the U1 snRNA genes described above were subcloned as HindIII-EcoRI fragments into the in vitro transcription vector pGEM-4Z (Promega). 32 P-labeled RNA complementary to U1 was prepared by T7 RNA polymerase transcription of SalI-cleaved DNA with [α-32 P]UTP. Aliquots of 5-10 µg of total yeast RNA were hybridized with 100 000-500 000 c.p.m. of uniformly labeled, gel-purified RNA probe for 1 h at 65_C in 20 µl of solution R1 (0.9 M NaCl, 7.5 mM EDTA, pH 7.4). Next, 105 µl of solution R2 (5 mM EDTA, pH 7.4, 0.5 U RNase One™; Promega) was added and the sample digested at room temperature for 1 h. After phenol extraction, the protected RNA fragments were resolved on a denaturing 7 M urea-6% polyacrylamide gel together with RNA molecular weight markers. The markers used included in vitro transcripts of EcoRI-cleaved pTZ19U (61 nt), PvuII-cleaved pTZ19U (149 nt), HindIII-cleaved U1 pGEM-4Z (769 nt), HindIII-cleaved U1∆192-507 (462 nt) and BamHI-cut 25S rDNA (228 nt; S.Abou Elela and M.Ares, personal communication). One nucleotide has been added to the size of the markers to account for the inclusion of a CAP analog, diguanosine triphosphate (Pharmacia), in the reaction mixture. To more precisely map the RNase digestion products, the RNAs were also resolved adjacent to an RNA sequence (37) of 3′-end-labeled U1∆192-507 RNA.
RNA from yeast that express GAL::U1 (strain XLT10-pXL46), GAL::U1, U1Sm (strain RSY2), U1∆192-507 (strain PSU1∆192-507), GAL::U1, U1∆192-507Sm (strain RSY1) and U1 (strain TS192) were analyzed by this method.
The 5′-ends of the various U1 transcripts were mapped by primer extension with 5′-end-labeled oligonucleotide U1-16, complementary to nucleotides +26 to +45 of U1. For each reaction, 10 µg of total yeast RNA and 3 U of avian myeloblastosis virus reverse transcriptase were used (Life Sciences Inc., St Petersburg, FL) under conditions previously described (38) . A DNA sequence generated with the same primer and the U1∆192-507 subcloned gene was run in parallel to determine the lengths of the extension products. RNA from yeast that express GAL::U1 (strain XLT10-pXL46), U1∆192-507 (strain PSU1∆192-507) and GAL::U1, U1∆192-507Sm (strain RSY1) were analyzed by this method.
In vitro RNase III reactions
RNase III digestions were done in yeast extract by incubating the synthetic RNA precursor substrate (∼100 000 c.p.m.) with 30% (v/v) yeast splicing extract (39), 2.5 mM MgCl 2 , 3% polyethylene glycol (average mol. wt 8000), 100 mM KHPO 4 (pH 7.2) and 2 mM ATP in a final volume of 10 µl. After 1-10 min at 30_C the reactions were stopped by the addition of 100 µl of PK buffer (100 mM Tris-HCl, pH 7.5, 12.5 mM EDTA, 150 mM NaCl, 1% SDS, 2 mg/ml proteinase K; Gibco BRL) for 5 min at 37_C. The RNAs were recovered by phenol extraction and ethanol precipitation and then resolved by denaturing gel electrophoresis with the untreated substrate and the molecular weight standards described above. The RNAs used for RNase III digestion included the T7 RNA polymerase transcribed BamHI-cut 25S rDNA control substrate and the SP6 RNA polymerase transcribed HindIII-cut U1 pGEM-4Z derivatives. In some experiments 5′-end-labeled RNA (40) or 3′-end-labeled RNA (38) was substituted for the uniformly labeled RNA.
Purified GST-Rnt1p, a kind gift of M.Ares and S.Abou Elela (26), was also used to map RNase III cleavage sites in the synthetic U1 snRNA precursors. Here, 0.5 µl of Rnt1p was added to a 10 µl reaction composed of the RNA substrate and R3 buffer (30 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 5 mM spermidine, 30 mM KCl, 0.1 mg/ml wheat germ tRNA) (26) . After 1-10 min the reactions were terminated as described for the yeast extract cleavages and the samples analyzed by denaturing gel electrophoresis.
RESULTS
The 3′-terminal U1 Sm site is essential in vivo
The yeast U1 snRNA has three sequence elements that match the Sm site consensus. Two of the three sites are found within a double-stranded region of the internal yeast-specific domain (positions 224-230 and 241-247) and can be deleted without obvious loss of U1 function (31, 41) . The third resides at the more characteristic Sm site location near the 3′-end of the transcript (position 553-559). To test whether the 3′-terminal site was essential for U1 snRNA activity, we replaced the natural Sm sequence, AUUUUUGA, with a different sequence of equivalent length, AUUCACAC. This mutation was introduced into a plasmid-borne copy of the natural full-length SNR19 gene and into a functional deletion derivative that lacked the first two Sm sites (U1∆192-507; 31). The shorter derivative, U1∆192-507Sm, allowed for clean resolution of the mutant RNA from a co-expressed wild-type U1 RNA. In addition, the parallel use of U1Sm and U1∆192-507Sm mutants permitted assessment of the 3′-terminal Sm site activity in the presence and absence of the potentially compensatory upstream sites.
The U1 derivatives were transformed into a yeast strain that contained a chromosomal null allele of SNR19 (27) and a plasmid-borne U1 gene allele under the transcriptional control of the GAL10 promoter (GAL::U1; 42). While natural promoters are required for proper U snRNA processing in vertebrates (43) (44) (45) , GAL10-driven yeast snRNAs are functional and appear to be processed normally (6,46-49; below) . Neither the full-length mutant, U1Sm, nor the deletion derivative, U1∆192-507Sm, produced a dominant negative phenotype when co-expressed with GAL::U1 (Fig. 1A, -tryptophan +galactose) . To test for function, the transformants were streaked on medium that repressed GAL::U1 transcription and selected against the physically linked URA3 gene (Fig. 1A, +5 -FOA, +glucose). As expected, the U1∆192-507 allele compensated for the loss of GAL::U1 expression and colonies formed on the 5-FOA plates. In contrast, the U1Sm and U1∆192-507Sm mutants did not form colonies and appeared, therefore, to be defective in U1 function. Consistent with a primary defect in pre-mRNA splicing, transcriptional repression of GAL::U1 caused cellular mRNA to decrease and pre-mRNA to accumulate in yeast transformed with U1Sm or U1∆192-507Sm (Fig. 1B and data not shown) . Thus, the terminal Sm site of the U1 snRNA gene is both necessary and sufficient to support in vivo pre-mRNA splicing.
Interference with Sm site-protein interactions causes the accumulation of lengthened forms of U1 snRNA GAL::U1 yeast co-transformed with U1∆192-507 accumulated RNAs corresponding to the predicted lengths of the fully processed 568 nt U1 and 258 nt U1∆192-507 species ( Fig. 2A , termed U1α and U1∆α, respectively). In contrast, U1∆α was not detected in yeast co-transformed with the U1∆192-507Sm mutant. Rather, a prominent RNA band ∼75 nt longer, U1∆β, accumulated in the Sm mutant (compare lane 1 with lanes 2-4). A variable amount of a third, more diffuse RNA, U1∆γ, was also observed in the U1∆192-507Sm transformant. Transcriptional repression of GAL::U1 reduced U1α levels but not U1∆β or U1∆γ, showing that these alternative snRNA forms were not transcribed from the GAL10 fusion construct. Equivalent results were obtained when U1Sm was introduced as a mutant construct, although a prominent U1γ form was not observed (Fig. 2B) . Thus, for both U1 and U1∆192-507, mutation of the terminal Sm site was lethal and caused the accumulation of extended U1 snRNA derivatives.
The Sm sequence might contribute directly to the processing of the U1 snRNA or act indirectly through the association of the Sm-bound common snRNP polypeptides. To address this question, we asked whether an alternative means to perturb the Sm RNP structure produced a similar pattern of U1 snRNA forms. Yeast were assayed for U1 snRNA length both before and after transcriptional repression of the nutritionally regulated GAL::SMD1HA fusion gene which encodes the essential Smd1p common snRNP protein tagged with a hemagglutinin epitope (5,8; with the Sm site change, U1∆α levels decreased and U1∆β and U1∆γ levels increased with depletion of the Sm-associated Smd1HAp protein (Fig. 2C) . Thus, the RNP structure of the Sm site plays an important role in U1 snRNA 3′-end formation.
Extended forms of U1 snRNA have additional 3′-sequence
It is of interest that while lower in abundance, the U1∆β and U1∆γ RNAs are present in yeast transformed with the functional U1∆192-507 construct (Fig. 3, lanes 1 and 3) . Oligonucleotidedirected RNase H digestion was used to confirm that these RNAs were truly derived from the U1 gene. An oligo complementary to U1 nt 170-189 directed RNase H cleavage of the U1∆α, U1∆β and U1∆γ RNAs (lane 2). Each U1 band was also cleaved with oligonucleotides directed against U1 nt 26-45 and 130-148 but not with the control oligonucleotide, 381-1 (lane 1 and data not shown). Equivalent results were obtained with the U1-specific oligonucleotides when U1∆192-507Sm-derived RNA was used as an enriched source of the U1∆β and U1∆γ RNAs (data not shown). When oligo(dT) 20 was used to direct RNase H cleavage, the U1∆γ band was selectively lost (compare lanes 3 and 4). U1∆γ was also selectively enriched by oligo(dT) chromatography (data not shown). Since no extended poly(A) tracts flank the U1 gene (23,24) the U1γ oligo(dT) 20 sensitivity is most likely due to post-transcriptional modification. RNase H treatment of the U1∆192-507Sm-derived RNA with oligo(dT) 20 likely shifts U1∆γ to the U1∆β position since no novel product was generated by this treatment (Fig. 3B) . Taken together, the RNase H digestion results indicate that U1∆β and U1∆γ are transcribed from the U1∆192-507 allele and that U1∆γ is a polyadenylated U1 derivative of U1∆β.
While not definitive, the lengths of the RNase H products relative to the oligonucleotide binding sites suggested that U1∆α, U1∆β and U1∆γ RNAs shared a common 5′-end. Primer extension analysis confirmed that GAL::U1, U1∆192-507 and U1∆192-507Sm all initiated transcription at the previously reported 5′ adenosine (Fig. 4A, lanes 1-4; 23,24 ). In the case of U1∆192-507Sm, the RNA was assayed both in the presence of the wild-type U1 (lane 3) and after transcriptional repression depleted U1α to nearly undetectable levels (lane 4). Since the cDNA produced was the same length, U1∆β must differ from U1α due to heterogeneity 3′ of the primer binding site.
An RNase protection assay (36) was used to map the 3′-ends of the U1 derivatives (Fig. 5B) . Cellular RNA was hybridized to a uniformly labeled probe that extended from U1 snRNA nt 508 to a position 191 nt downstream of the natural U1 3′-end (23, 24) . The cellular U1∆192-507 RNA protected probe fragments of between 61 and 69 nt (Fig. 4B, lane 4, and C, lane 3) ; a 66 nt product corresponds to the published 3′-end of U1α snRNA (23, 24) . The high A+U content of the 3′-end likely contributes to the minor heterogeneity of the RNase digestion products. GAL::U1 and wild-type U1 produced equivalent fragments, foreshortened by 6 nt due to a linker inserted in the 3′-end of the U1∆192-507 probe (31; Fig. 4B , lane 2, and C, lanes 2 and 4; Materials and Methods). GAL::U1-containing yeast that simultaneously expressed U1Sm or U1∆192-507Sm also produced the U1α RNA fragment (45 nt, *) but this band was much reduced after glucose repression of GAL::U1 (compare lane 2 with 3 and 5 with 6). In addition, yeast with Sm mutant genes produced a large amount of RNA that is 64-78 nt longer than the mature U1 snRNA, termed U1∆β (lanes 5 and 6) and U1β (lanes 2 and 3) . Together, the RNase mapping data show that unlike the vertebrate system (43-45,50) a major step in yeast U1 snRNA 3′-end formation requires the Sm site and is not promoter dependent.
RNase III cleaves U1 snRNA precursors
Synthetic U1 snRNAs were produced to investigate whether extended U1 snRNA could be processed by yeast splicing extract. These uniformly radiolabeled RNAs consisted of the U1∆192-507 or U1 mature RNA sequences followed by 190 and 188 nt of downstream sequence, respectively. Both pre-U1∆192-507 (Fig. 5A, lanes 2-10) and pre-U1 (lane 11) RNAs were efficiently cleaved to produce five additional bands (Fig. 5A, labeled B-F) . When the pre-U1∆192-507 RNA was 5′-end-labeled only bands A-C were visible. Band A is the uncut precursor while bands B and C correspond to stable RNA products that end 80 and 115 nt, respectively, downstream of the U1α 3′-end observed in vivo (Fig. 5B) . Band B was present only in the earliest time points suggesting that it is an intermediate in the processing reaction. When the pre-U1∆192-507 snRNA was 3′-end-labeled before processing, bands D and E were present in the final reaction products. The 3′-end-labeled D and E RNAs were cleaved at positions 75 and 110 upstream of the 3′-end of the synthetic precursor (Fig. 5B) . Of the six RNA forms observed, the 35 nt F band was the only internally derived fragment (i.e. was not found as a 5′-or 3′-end-labeled species) and was derived from a double cleavage at positions 75 and 110 upstream of the 3′-end. Pre-U1 snRNA was processed at precisely the same nucleotides as the pre-U1∆192-507 derivative, showing that the processing reaction was not significantly influenced by the large internal deletion (compare lanes 5 and 11) .
The electrophoretic pattern of 5′-and 3′-labeled products was consistent with endonucleolytic cleavages of the synthetic U1 pre-snRNA. Recently, the yeast RNT1 gene product, Rnt1p (RNase III), was shown to cleave the 3′-ends of synthetic U2 and U5 snRNA precursors (25, 26) . Two experiments were performed to determine whether RNase III was responsible for the U1 snRNA cleavages. First, processing in the wild-type extract was compared with that observed in an extract prepared from an rnt1::HIS mutant strain (Fig. 6, RNT1 and rnt1::HIS3, respectively) . The RNT1 extract efficiently cleaved a 228 nt 25S rRNA control substrate at the expected positions, 15 and 50 nt from the 3′-end (lanes 2, 4 and 6-14; S.Abou Elela and M.Ares, personal communication; 28). The synthetic U1∆192-507 precursor was cleaved by the RNT1 extract in the presence or absence of the control substrate (Fig. 6, lanes 3 and 5) (6-8) . In contrast, neither RNA was processed by the rnt1::HIS3 extract (lanes 9-11). Lack of cleavage was not due to a general poor quality of the extract since the RNT1 and rnt1::HIS3 extracts had equivalent RNA and protein contents and both efficiently spliced pre-mRNA (data not shown).
As a second test of Rnt1p activity in U1 processing, recombinant Rnt1p, GST-Rnt1p, was incubated directly with U1 snRNA (lanes 12-14) . The pattern of cleavage was identical to that observed with the yeast extract except that band D, a possible intermediate in processing, was not found. The concordance of the RNA cleavage patterns adds support for endogenous Rnt1p being the U1 cleavage activity in the yeast extracts.
The Rnt1p cleavages are shown in Figure 7 in the context of a putative secondary structure downstream of the U1 mature 3′-end. The structure was predicted by RNAdraw with a ∆G of -28.01 kcal (51) . Similar structures were also generated by Mfold (52) . The cleavages are staggered by 2 nt on either side of a stem in a stem-loop structure. While we have no direct evidence that this structure forms in vivo or in vitro, similar structures and RNase III cleavage patterns have been presented for yeast U2 snRNA (25) , yeast U5 snRNA (26) , yeast snr190-U14 RNA (53), Figure 6 . In vitro Rnt1p cleavage of the synthetic pre-U1. Uniformly labeled pre-U1∆192-507 snRNA, U1∆192-507Sm snRNA and a 25S rRNA control substrate were incubated for the indicated times with a wild-type yeast extract (RNT1, lanes 4-8; 15), the rnt1::HIS3 mutant extract (lanes 9-11) or with purified GST-Rnt1p (lanes [12] [13] [14] . Lane 1 contains the molecular weight markers and lanes 2 and 3 the unreacted rRNA control and U1∆192-507 substrates, respectively. An asterisk in lane 4 indicates the major resolvable rRNA cleavage product; the U1∆192-507-derived substrates and products are indicated by arrows. yeast 25s rRNA (28), E.coli 16S rRNA, E.coli 23 rRNA, E.coli rnc RNA, E.coli rpsO-pnp RNA, E.coli met-orf15A-nusA RNA, E.coli sib3 RNA, the bacteriophage λ N-leader RNA and T7 bacteriophage RNA (reviewed in 54).
While GST-Rnt1p is able to cleave synthetic U1 snRNA precursors, mutation of this gene does not appreciably decrease the intracellular abundance of fully mature U1α snRNA ( Fig. 8;  26) . However, another RNA species, U1ε, was much increased in the rnt1::HIS3 mutant yeast. U1ε migrates above U1β as a closely spaced doublet ∼750 nt in length. U1ε is a 3′-extended form as this RNA hybridized both with a probe restricted to the U1α sequence as well as with a probe that extended from the U1α 3′-end to the HindIII site located 192 nt downstream (Fig. 8) . U1ε may not be polyadenylated since its electrophoretic mobility is insensitive to RNase H digestion with oligo(dT) 20 (data not shown). However, given the large size of U1ε, a short poly(A) tail might not be detectable by this method. Since the levels of U1ε were reduced when the rnt1::HIS3 mutant was complemented by a plasmidborne copy of RNT1 (Fig. 8, compare lanes 3 and 4) , U1ε abundance directly relates to the endogenous levels of RNase III. Based on this, we conclude that Rnt1p, while not required for U1 snRNA maturation, does influence steady-state levels of 3′-extended U1 snRNAs.
DISCUSSION
Although three sites corresponding to the Sm consensus are present in yeast U1 snRNA, only the 3′-terminal Sm site is required for splicing. This result is consistent with a proposed secondary structure of yeast U1 snRNA (55) in which only the 3′-terminal Sm element is present as a characteristic single- stranded element (3, 4) . Both upstream Sm-like sites are predicted to be partially or fully base paired with other regions of the yeast-specific core (55) . The location of the final site is directly downstream of a base paired segment joining the two ends of the snRNA (the closure sequence; 23,56), is within 8 nt of the 3′-end of the mature transcript and is well placed for an element that participates in 3′-end maturation. Here we demonstrate a pivotal role for the Sm site and its associated proteins in the biosynthesis of yeast U1 snRNA.
Two prominent forms of 3′-extended U1 snRNA are found in yeast, a non-polyadenylated snRNA extended 64-78 nt (U1β) and a related polyadenylated form (U1γ). Several lines of evidence suggest that one or both of these snRNAs may be precursors to U1 snRNA. First, 3′-extended biosynthetic precursors are the rule rather than the exception for pol II transcripts (57) and recent studies have suggested that 3′-extended precursor forms of U2 and U5 snRNAs exist in yeast (6, 25, 26, 58) . Second, the 3′-extended U1 snRNA species are observed in low abundance in wild-type yeast but increase in abundance with experimental manipulation of the Sm site or the Smd1p core protein (Fig. 2 and data not shown). This impact of Smd1HAp depletion is consistent with a build-up of precursors (U1∆β and U1∆γ) resulting from a kinetic barrier to product formation (U1∆α). Inactivation of the common snRNP protein Brr1p slows conversion of the putative U2 precursor to its mature form (6) . Although Brr1p has not been shown to be part of the Sm core particle, this protein interacts genetically with Smd1p and the removal of either activity produces similar defects in snRNA stability and cap modification (5, 6, 8) . Third, like the U2 and U5 snRNAs (25, 26) , U1 has a pair of Rnt1p cleavage sites located downstream of the mature snRNA (Figs 5 and 6 ). In each case the rnt1::HIS3 mutation changes the wild-type level of the snRNA. The steady-state levels of mature U2 and U5L snRNA, but not U1 snRNA, decrease in the rnt1::HIS3 background. For U2, but not U1, the rnt1::HIS3 mutation also results in a large increase in polyadenylated 2 and 4) and the same strain carrying a plasmid-borne RNT1 gene (lanes 1 and 3) was analyzed by northern blot. The membrane was probed with the 568 nt U1 gene body (probe A) and with a PCR probe prepared from the sequences beginning at the natural U1 3′-end and extending downstream 180 nt (probe B). U1α represents mature U1; U1ε represents a U1-derived RNA ∼750 nt long. On longer exposure, the low abundance U1ε band can also be observed with probe A (data not shown). The low level of U1α observed with probe B results from a trace amount of PCR template present in this preparation. U1α is much more abundant than U1ε; the U1ε:U1α ratio with probe B does not reflect the relative intracellular abundance of these RNAs.
snRNA. Taken together, the available data support the view that the pol II spliceosomal snRNAs are matured at their 3′-ends through similar though not necessarily identical means.
Xenopus laevis, human and mouse U1 molecules are synthesized as nuclear precursors with 10-12 nt extensions (59) (60) (61) (62) that are trimmed to having one or two extra nucleotides in the cytoplasm (59, 60) . A nuclear activity has been identified that specifically removes the remaining nucleotide of the U1 precursor (50), consistent with the observation that mature U1 snRNAs are exclusively nuclear (50, 60) . Since in vertebrates the Sm site is not required for nuclear export (63) , the initial step of snRNA processing is Sm site-independent. In contrast, the general inhibition of nucleocytoplasmic exchange by vesicular stomatitis viral infection (64, 65) or viral M protein expression (66) inhibits the processing reaction and results in the accumulation of nuclear snRNA precursors. If yeast behaves similarly, the Sm site mutation would trap U1 precursors in the cytoplasm. In this case, the 3′-extended U1β RNA might be viewed as a much longer version of the vertebrate +1 cytoplasmic species. It is not clear why the 3′-extensions of the yeast Sm mutant are not processed more closely to the natural 3′-end, as in vertebrates. It is possible, however, that in yeast the Sm site mutation inhibits nuclear export and the extended RNAs are completely nuclear and thus unavailable to a cytoplasmic processing activity. Enhanced nuclear retention might also lead to promiscuous polyadenylation and, hence, the observed increased levels of U1∆γ observed with the Sm site change. However, since depletion of Smd1p also results in increased U1∆γ levels (Fig. 2C) , one would need to argue that: (i) Smd1p binds prior to nuclear export (in contrast to vertebrates; 67,68); (ii) Smd1p assists in the removal of polyadenylated tails; or (iii) that U1∆γ levels may increase due to an indirect consequence of splicing inhibition that occurs with Smd1p depletion.
U1 snRNA is an efficient substrate for Rnt1p and is processed almost identically in yeast extract and with the purified enzyme. Thus, it seems almost certain that Rnt1p, not an Rnt1p-cleaved catalytic RNA, contains the observed U1 processing activity in yeast. A minor difference noted between the extract and Rnt1p processing results was that band D, generated in the yeast extract, Figure 9 . Model for U1 snRNA 3′-end formation. U1 snRNA appears to be processed along two alternative pathways. One pathway uses Rnt1p (yeast RNase III) to process the RNA to an intermediate state, U1β, which may become polyadenylated. An unknown activity, likely an exonuclease, is required to process U1β to the mature U1α form. This activity may also be able to process the putative U1 precursor, U1ε, directly to U1α. However, in both cases, U1α formation in vivo passes through an Sm-dependent step. The closed circle represents the U1 gene body, while the sequence/structure represents the RNA including and downstream of the mature U1 3′-end.
was not observed with purified Rnt1p. However, band D is a singly cleaved precursor RNA form (Fig. 6 ) and this difference may simply reflect a more efficient processing by the purified enzyme into the doubly cleaved E and F RNAs. U5 snRNA is also readily cleaved by Rnt1p at sites located 26-27 (pre-U5L) and 90-91(pre-U5S) nt downstream of the mature ends (26) . In this case, however, the cleaved products are then processed further by an uncharacterized nuclease to 3-4 nt downstream of the natural U5 3′-ends (26) . In vitro, U1 snRNA is a much less favored substrate for the second nuclease activity since little or no U1 is processed beyond the Rnt1p cleavage sites (Figs 5 and 6 and data not shown). It remains to be determined whether cis-inhibitory elements or missing trans-acting factors account for this difference.
Model of U1 biosynthesis
The following model accounts for our experimental observations and offers a framework for future experimentation (Fig. 9 ). In the rnt1::HIS3 mutant we observe a U1 snRNA form extended by at least 180 nt, U1ε. We propose that U1ε is a U1 snRNA precursor, perhaps formed by transcriptional termination, and that Rnt1p cleaves U1ε at positions 80 and 115 from the mature 3′-end to form U1β. U1β may then be processed through an Sm-dependent pathway to mature U1α RNA. Alternatively, U1β may be polyadenylated to form U1γ. Since polyadenylated spliceosomal snRNAs have not been observed (23, 24, (69) (70) (71) , U1γ may reflect promiscuous polyadenylation enhanced by kinetic impairment of the normal processing pathway. Alternatively, as speculated for an unexpected form of polyadenylated telomerase RNA (72) , snRNAs may normally cycle between polyadenylated and deadenylated species.
In the absence of Rnt1p, mature U1α still forms as long as the U1 Sm site is intact. Consequently, U1ε or a related molecule must be processed directly to the Sm-dependent (U1β) form. While yeast U2 snRNA maturation is fully Rnt1p-dependent (25) , an Rnt1p bypass pathway has been suggested to account for U5S formation (26) . The cellular benefit of dual pathways is unknown, but not unreasonable to contemplate. Perhaps the Rnt1p-dependent (or -independent) pathway contributes to the efficiency of U1 production at times of environmental stress or at certain times of the cell cycle. Alternatively, as shown for the dicistronic snoRNAs U14 and snr190, Rnt1p cleavage of U1 precursors may contribute to the formation of an uncharacterized co-transcribed downstream RNA (53) .
Clearly, the pathway for yeast U1 snRNA biosynthesis is complex and has features that distinguish it from what has been observed for vertebrate U1 and for yeast U2 and U5 snRNAs. Future experiments will be required to test the validity of our dual pathway model and to identify the Sm-dependent and -independent enzymatic activities required for U1 3′-end formation.
